The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

Kettering General Hospital has set up a £250,000 state-of-the-art one-stop ophthalmology suite for patients who need ...

A hospital has launched a specialist "state-of-the-art" £250,000 ophthalmology suite for eye procedures. Kettering General ...

A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...

Izervay (avacincaptad pegol) is a prescription injection used to treat severe age-related macular degeneration (AMD). Izervay can cause side effects that range from mild to serious. Examples ...

Faricimab helped improve vision in previously untreated patients with neovascular age-related macular degeneration, according ...

The new funding will allow the company to complete its ongoing Phase 2 trial of proprietary nanomedicine, migaldendranib, in ...

Age-related macular degeneration may cause a gradual reduction in your central vision over time, so you might not recognize AMD at first.

Mississauga, Ontario Tuesday, January 21, 2025, 14:00 Hrs [IST] ...